<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000535498"><TermName>topoisomerase II inhibitor RTA 744</TermName><TermPronunciation>(TOH-poh-i-SAH-meh-rays ... in-HIH-bih-ter ...)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of adult brain tumors. Topoisomerase II inhibitor RTA 744 crosses the blood-brain barrier and blocks an enzyme needed for cancer growth. It is a type of topoisomerase inhibitor. Also called RTA 744.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718388" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;topoisomerase II inhibitor RTA 744&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718389" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de la topoisomerasa II RTA 744&quot;" language="es" id="_4"/><SpanishTermName>inhibidor de la topoisomerasa II RTA 744</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de los tumores cerebrales en adultos. El inhibidor de la topoisomerasa II RTA 744 cruza la barrera hematoencefálica y bloquea una enzima que el cáncer necesita para crecer. Es  un tipo de inhibidor de la topoisomerasa. También se llama RTA 744.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-02-12</DateFirstPublished><DateLastModified>2008-11-14</DateLastModified></GlossaryTerm>
